Antonis Makrigiannakis Selected Research

ceforanide

9/2005

Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonis Makrigiannakis Research Topics

Disease

6	Neoplasms (Cancer) 10/2019 - 05/2002
5	Endometriosis 01/2014 - 11/2012
4	Inflammation (Inflammations) 01/2014 - 04/2004
3	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2013
3	Infertility (Sterility) 01/2014 - 02/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020 - 10/2019
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2019 - 01/2011
2	Endometrial Neoplasms (Endometrial Cancer) 05/2017 - 02/2013
2	Trophoblastic Neoplasms (Trophoblastic Tumor) 01/2013 - 02/2012
2	Insulin Resistance 01/2011 - 09/2005
2	Habitual Abortion (Recurrent Miscarriage) 12/2010 - 05/2007
2	Spontaneous Abortion (Miscarriage) 12/2010 - 05/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2010 - 04/2006
2	Pre-Eclampsia (Preeclampsia) 07/2007 - 01/2006
2	Infections 09/2005 - 11/2002
1	Pain (Aches) 11/2020
1	Vaginal Diseases 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2018
1	Bites and Stings (Sting) 10/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Carcinogenesis 01/2017
1	Circulating Neoplastic Cells 01/2017
1	Smooth Muscle Tumor 02/2013
1	Myoma 02/2013
1	Leiomyoma (Uterine Fibroids) 02/2013
1	Leiomyosarcoma 02/2013
1	Carcinoma (Carcinomatosis) 02/2013
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 11/2012
1	Choriocarcinoma 02/2012
1	Hyperandrogenism 01/2011
1	Atherosclerosis 03/2010
1	Atherosclerotic Plaque (Atheroma) 03/2010
1	Rheumatoid Arthritis 01/2010
1	Hemolysis 07/2007
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2007
1	HELLP Syndrome 07/2007
1	Factor XII Deficiency 05/2007
1	Premature Menopause 04/2006
1	Primary Ovarian Insufficiency 04/2006

Drug/Important Bio-Agent (IBA)

4	Estrogens (Estrogen)FDA Link 03/2013 - 04/2006
4	Proteins (Proteins, Gene)FDA Link 01/2013 - 11/2003
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 10/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2011
2	Growth Factor ReceptorsIBA 01/2017 - 02/2013
2	NeuropeptidesIBA 01/2014 - 01/2013
2	Estrogen ReceptorsIBA 03/2013 - 11/2012
2	GTP-Binding Proteins (G-Protein)IBA 03/2013 - 11/2012
2	Hormones (Hormone)IBA 03/2013 - 04/2006
2	Corticotropin-Releasing HormoneIBA 02/2013 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2013 - 12/2010
2	Progestins (Progestagens)IBA 03/2010 - 04/2006
2	Platelet Endothelial Cell Adhesion Molecule-1IBA 10/2004 - 05/2002
2	AntibodiesIBA 11/2002 - 05/2002
1	AutoantibodiesIBA 10/2018
1	InterferonsIBA 10/2018
1	Mitochondrial DNA (mtDNA)IBA 10/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	2,2'-azobis(2-amidinopropane) (ABAP)IBA 05/2017
1	alpha-tocopherol transfer proteinIBA 05/2017
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Galectin 1 (LGALS1)IBA 01/2014
1	Galectins (Galectin)IBA 01/2014
1	Galectin 3 (LGALS3)IBA 02/2013
1	Formaldehyde (Formol)FDA Link 02/2013
1	ParaffinIBA 02/2013
1	Mucin-1 (CA 15-3 Antigen)IBA 02/2013
1	Fas Ligand Protein (Fas Ligand)IBA 02/2013
1	UrocortinsIBA 01/2013
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2013
1	LignansIBA 01/2013
1	Phytoestrogens (Phytoestrogen)IBA 01/2013
1	N 30IBA 11/2012
1	Tocopherols (Tocopherol)IBA 02/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	CytokinesIBA 06/2011
1	Pioglitazone (Actos)FDA Link 01/2011
1	Insulin (Novolin)FDA Link 01/2011
1	Interleukin-15 (Interleukin 15)IBA 12/2010
1	GlycodelinIBA 05/2010
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2010
1	Glycoproteins (Glycoprotein)IBA 05/2010
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2010
1	Sialyl Lewis X AntigenIBA 07/2007
1	EnzymesIBA 07/2007
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 07/2007
1	Blood Group Antigens (Blood Groups)IBA 07/2007
1	Lewis Blood Group AntigensIBA 07/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2007
1	Plasminogen InactivatorsIBA 05/2007
1	Factor XII (Hageman Factor)IBA 05/2007
1	Factor XIII (Coagulation Factor XIII)IBA 05/2007
1	SteroidsIBA 04/2006

Therapy/Procedure

2	Therapeutics 03/2010 - 01/2010
1	Secondary Prevention 10/2019
1	Adjuvant Chemotherapy 01/2017
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 04/2006